Though each subtype of breast cancer has both “cold” and “hot” tumors, TNBCs often have tumors with >50% lymphocytic infiltration and have higher PD-L1 expression5,31, which indicate that TNBCs may be the most sensitive to anti-PD-L1 therapy among breast cancer. The gene discussed is CD274; the disease is breast carcinoma.